期刊文献+

清络通痹方对类风湿关节炎患者T淋巴细胞表达RANKL的影响(英文) 被引量:1

Effect of Qingluo-tongbi Granule on RANKL Expression of T Lymphocytes Extracted from RA Patients
下载PDF
导出
摘要 目的研究清络通痹方(Qingluo-Tongbi Grannual,QLT)对类风湿关节炎(rheumatoid arthritis,RA)患者外周血T淋巴细胞表达RANKL(receptor activator of nuclear factor-κB ligand,破骨细胞分化因子)的影响。方法临床纳入15例RA患者,肘静脉抽血10ml,每个血样分为5组,包括正常对照组,阳性对照组,和QLT小、中、大三个剂量组。血样加药培养72小时后,加入FITC标记的CD3抗体和PE标记的RANKL抗体,采用流式细胞术检测RANKL的表达率。结果采用中剂量和大剂量QLT动物含药血清培养的T淋巴细胞RANKL表达率受到了显著的抑制,与正常对照组比较具有统计学差异(P<0.01)。结论 QLT可以有效下调RA患者外周血T淋巴细胞RANKL的表达。 Objective To study the effect of medicated serum containing Qingluo - tongbi Granule (QLT) on RANKL ( receptor activator of nuclear factor - KB ligand) expression of T lymphocytes extracted from peripheral blood of rheumatoid arthritis (RA) patients. Methods Blood samples extracted from veins of 15 RA cases were divided into 5 groups, including normal control, positive control, small - dose QLT, medium - dose as well as large - dose. Samples were cultured, processed under general program and tested with flow cytometer after antibodies of FITC labeled anti -human CD3 and PE labeled anti -human RANKL were added in. Results Compared with normal control group, RANKL expression of T lymphocytes treated with serum containing medium or large dose QLT was inhibited obviously in vitro ( P 〈 0.01 ), and QLT demonstrate effect to suppress RANKL expression. Conclusion QLT is able to suppress RANKL over - expression of T lymphocytes of RA patients.
机构地区 南京中医药大学
出处 《时珍国医国药》 CAS CSCD 北大核心 2012年第2期465-467,共3页 Lishizhen Medicine and Materia Medica Research
基金 this study is supported by Scientific Research Launching Fund of China Education Ministry for Returnees(No.2006331) Jiangsu Provincial Innovation Foundation For Postgraduate(No.2010)~~
关键词 清络通痹 类风湿关节炎 破骨细胞分化因子 流式细胞术 Qingluo - tongbi Rheumatoid arthritis RANKL
  • 相关文献

参考文献7

  • 1Damaris Vega, Naim M. Maalouf and Khashayar Sakhaee, The Role of Receptor Activator of Nuclear Factor - kB (RANK)/RANK Ligand/ Osteoprotegerin : Clinical Implications, J. Clin. Endocrinol. Metab,2007 92:4514.
  • 2Maxime Dougados, Paul Emery, Ernst- Martin Lemmel et al, Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6 - month data, The Journal of Rheumatology ,2009,36 ( 11 ) : 2435.
  • 3周学平,周仲瑛,金妙文,汪红,吴勉华,宋耀鸿,程海波.清络通痹颗粒治疗类风湿性关节炎阴虚络热证63例临床研究[J].中医杂志,2003,44(3):191-193. 被引量:23
  • 4Mot A, Abramson SB, Pillinger MH The fibroblast -like synovial cell in rheumatoid arthritis : a key player in inflammation and joint destruction. Clin Immunol,2005,115 ( 2 ) : 118.
  • 5Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T - cell growth and dendritic - cell function, Nature, 1997,390 ( 11 ) : 175.
  • 6Ziolkowska M, Kurowska M, Radzikowska A, et al. High levels of osteo- protegerin and soluble receptor activator of nuclear factor kB ligand in serum of rheumatoid arthritis patients and their normalization after anti- tumor necrosis factor treatment. Arthritis Rheum,2002,46 ( 7 ) : 1744.
  • 7J. A. M. Wessels,T. W. J. Huizinga and H. -J. Guchelaar,Recent in- sights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis, Rheumatology ,2008,47 ( 3 ) :249.

二级参考文献4

共引文献22

同被引文献55

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部